IP Library Granted Patent US 11,957,379
Granted Patent B2
US 11,957,379 · App. 17/109,340 · Granted Apr 16, 2024

Tissue interface apparatus, systems, and methods

Inventors: J. Ryan Stanfield (Sandy, UT); James W. Long (Edmond, OK); Michael A. Vladovich (Edmond, OK)
Assignee: STAR BP, INC.
A61B17/3423A61B17/00234A61B17/3468A61B17/3496A61B2017/3435A61B2017/348A61M2210/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,957,379
App. No.
17/109,340
Granted
Apr 16, 2024
Kind
B2
Abstract

In an aspect, a device includes a body structure including a core and a sleeve disposed around at least a portion of the core, the core defining a channel through the core extending from a first end of the core to a second end of the core, the sleeve including a flange adjacent the second end of the core; and a deployable portion coupled to the body structure adjacent the first end of the core, the deployable portion having a wired structure transitionable between a retained configuration and a deployed configuration, wherein a top portion of the wired structure extends beyond the first end of the core in a longitudinal direction when the wired structure is in the retained configuration, and wherein first end of the core extends beyond the top portion of the wired structure when the wired structure is in the deployed configuration.

Claims (27)

1. A biologic tissue interface device comprising:

a body structure including a core and a sleeve disposed around at least a portion of the core, the core defining a channel through the core extending from a first end of the core to a second end of the core; and

a flange coupled to at least one of the sleeve or the core adjacent the second end of the core,

wherein the core includes an outer surface having an angled slope narrowing toward the channel in a longitudinal direction from the second end of the core to the first end of the core.

2. The biologic tissue interface device of claim 1 , wherein the flange is formed from at least one of nitinol, stainless steel, cobalt chromium, or alloys thereof.

3. The biologic tissue interface device of claim 1 , wherein the flange is coupled to an outer surface of the sleeve.

4. The biologic tissue interface device of claim 1 , wherein the flange is coupled to the outer surface of the core adjacent the second end of the core.

5. The biologic tissue interface device of claim 1 , wherein the core includes a first flange adjacent the first end and a second flange adjacent the second end, and wherein the sleeve is coupled between the first flange and the second flange.

6. The biologic tissue interface device of claim 1 , wherein the sleeve includes a fibrous material.

7. The biologic tissue interface device of claim 1 , wherein the sleeve includes at least one of a polytetrafluoroethylene (PTFE) felt, polyethylene terephthalate (PET), or bovine pericardium.

8. The biologic tissue interface device of claim 1 , wherein the flange includes a fibrous material coupled to an exterior surface of the flange.

9. The biologic tissue interface device of claim 1 , wherein the flange includes at least one of a polytetrafluoroethylene (PTFE) felt, polyethylene terephthalate (PET), or bovine pericardium coupled to an exterior surface of the flange.

10. The biologic tissue interface device of claim 1 , further including a hemostatic valve seal coupled to the core and covering the channel with a plurality of flexible members.

11. The biologic tissue interface device of claim 1 , further including a second flange coupled to the sleeve adjacent the first end of the core.

12. A biologic tissue interface system comprising:

a body structure including a core and a sleeve disposed around at least a portion of the core, the core defining a channel through the core extending from a first end of the core to a second end of the core;

a flange coupled to at least one of the sleeve or the core adjacent the second end of the core; and

a hemostatic valve seal coupled to the core and covering at least a portion of the channel,

wherein the core includes an outer surface having an angled slope narrowing toward the channel in a longitudinal direction from the second end of the core to the first end of the core.

13. The biologic tissue interface device of claim 12 , wherein the flange is formed from at least one of nitinol, stainless steel, cobalt chromium, or alloys thereof.

14. The biologic tissue interface device of claim 12 , wherein the flange is coupled to an outer surface of the sleeve.

15. The biologic tissue interface device of claim 12 , wherein the flange is coupled to the outer surface of the core adjacent the second end of the core.

16. The biologic tissue interface device of claim 12 , wherein the core includes a first flange adjacent the first end and a second flange adjacent the second end, and wherein the sleeve is coupled between the first flange and the second flange.

17. The biologic tissue interface device of claim 12 , wherein the sleeve includes a fibrous material.

18. The biologic tissue interface device of claim 12 , wherein the flange includes a fibrous material coupled to an exterior surface of the flange.

19. The biologic tissue interface device of claim 12 , wherein the hemostatic valve includes a plurality of flexible members positioned adjacent the second end of the core.

20. The biologic tissue interface device of claim 12 , further including a second flange coupled to the sleeve adjacent the first end of the core.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 2, 2023
From: INTEGRIS BAPTIST MEDICAL CENTER, INC.
To: VADOVATIONS, INC.
Reel/Frame 065090/0393 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2023
From: VADOVATIONS, INC.
To: STAR BP, INC.
Reel/Frame 065095/0718 →
SECURITY INTEREST Recorded Aug 12, 2021
From: VADOVATIONS, INC.
To: INTEGRIS BAPTIST MEDICAL CENTER, INC.
Reel/Frame 057181/0781 →
Continuity (3)
Continuation 16380338 · Apr 10, 2019
Provisional Application 62655937 · Apr 11, 2018
Related Publication 20210077146A1 · Mar 18, 2021